Drug Chatter -- Tracking biopharma stock chatter

Profile for Medivation, Inc. (MDVN)

« Back to company index

MDVN Chatter Timeline

Stock Ticker for MDVN

Most Active Tweeters for MDVN

UserTweets
@DrSManian 3
@nakatsu28 1
@ProVesting 1
@biotechnova 1
@ChartEyez 1

Recent Tweets for MDVN

ChartEyez @ChartEyez
RT @biotechnova: First hostile offer in the space since $MDVN https://t.co/RBceFWtfgA
January 8th 2018, 1:01am
biotechnova @biotechnova
First hostile offer in the space since $MDVN https://t.co/RBceFWtfgA
January 8th 2018, 1:01am
TranscriptDaily @TranscriptDaily
Somewhat Positive Press Coverage Somewhat Unlikely to Affect Medivation $MDVN Stock Price https://t.co/nSYiVL2wxe
January 7th 2018, 10:01pm
DrSManian @DrSManian
$VSTM New CCO ex $MDVN / XTAndi BoD Tim Barberich (ex Chairman Sepracor) huge insider buy last month This is likel… https://t.co/eOOs4hCGpJ
January 4th 2018, 2:01pm
DrSManian @DrSManian
@agamemnus_dev $VSTM appoints former CCO of $MDVN Joseph Lobacki, as CCO.
January 4th 2018, 9:01am
DrSManian @DrSManian
Solid addition to $VSTM as it gets ready to be a commercial stage enterprise Lobscki - Ex $MDVN CCO joining as CC… https://t.co/UpX3Xa7udl
January 4th 2018, 7:01am
ProVesting @ProVesting
$MDVN $PCYC: 2018 Biotech Investing Theme: Looking For Safety Plays: https://t.co/CJ5YFxOG6p
January 3rd 2018, 1:01pm
nakatsu28 @nakatsu28
RT @kristen_hallam: Astellas suspended from UK trade group over breaches of conduct re: Xtandi promotion $MDVN h/t @healthscicon https://t.…
January 2nd 2018, 10:01pm
ConsumerFeed @ConsumerFeed
Medivation $MDVN Earning Somewhat Favorable Media Coverage, Analysis Finds https://t.co/lmWPXOLhUW
December 30th 2017, 4:12pm
dakotafinancial @dakotafinancial
Medivation $MDVN Earning Somewhat Favorable Media Coverage, Analysis Finds https://t.co/5vv1hlN4r6
December 30th 2017, 4:12pm
1simpletrader @1simpletrader
$MDVN was bought out a few days later for $81.50 i believe. these patterns always repeat #study https://t.co/4W7dyhqXCz
December 30th 2017, 2:12pm
WeekHerald @WeekHerald
Medivation $MDVN versus The Competition Head-To-Head Survey https://t.co/7WWBbL4Vhc
December 28th 2017, 6:12pm
WatchlistN @WatchlistN
Medivation $MDVN Given Coverage Optimism Score of 0.22 https://t.co/VwQ7iaWl7l
December 26th 2017, 5:12pm
stocknewstimes @stocknewstimes
Medivation $MDVN vs. Spark Therapeutics $ONCE Head to Head Review https://t.co/gSMwGibUaE
December 25th 2017, 12:12pm
SleekMoneycom @SleekMoneycom
Medivation $MDVN vs. Spark Therapeutics $ONCE Head to Head Review https://t.co/qHXsEZ9rxI
December 25th 2017, 12:12pm
TheMarketsDaily @TheMarketsDaily
Medivation $MDVN vs. Spark Therapeutics $ONCE Head to Head Review https://t.co/86vwpefKXH
December 25th 2017, 12:12pm
dailymailtimes @dailymailtimes
Medivation $MDVN and Spark Therapeutics $ONCE Head to Head Review https://t.co/L9XIN8Z03L
December 23rd 2017, 9:12am
midetimes @midetimes
Medivation $MDVN and Spark Therapeutics $ONCE Head to Head Review https://t.co/a4irQNavdw
December 23rd 2017, 9:12am
WKRBNews @WKRBNews
Medivation $MDVN and Spark Therapeutics $ONCE Head to Head Review https://t.co/zXsB038NWU
December 23rd 2017, 9:12am
WatchlistN @WatchlistN
Deciphera Pharmaceuticals $DCPH versus Medivation $MDVN Head to Head Analysis https://t.co/5cdmjIekGT
December 23rd 2017, 12:12am
chaffeybreeze @chaffeybreeze
Head to Head Survey: Medivation $MDVN vs. Deciphera Pharmaceuticals $DCPH https://t.co/Znk8So8iwn
December 20th 2017, 4:12pm
IRAMarketReport @IRAMarketReport
Head to Head Survey: Medivation $MDVN vs. Deciphera Pharmaceuticals $DCPH https://t.co/dvGBNUZk0u
December 20th 2017, 4:12pm
renglebrecht @renglebrecht
@TCMLLC @Duckman1717 The first 100% gain is the hardest. Imagine when your stock gets bought out. Fun stuff! $MDVN
December 20th 2017, 1:12pm
WeekHerald @WeekHerald
Medivation $MDVN and Its Rivals Financial Survey https://t.co/7WWBbL4Vhc
December 19th 2017, 6:12pm
ConsumerFeed @ConsumerFeed
Analyzing Medivation $MDVN and Spark Therapeutics $ONCE https://t.co/ik22st5Crp #acn
December 18th 2017, 11:12pm
CFinancialNews @CFinancialNews
Analyzing Medivation $MDVN and Spark Therapeutics $ONCE https://t.co/1b0lXEQ6T0
December 18th 2017, 11:12pm
AmericanBanking @AmericanBanking
Analyzing Medivation $MDVN and Spark Therapeutics $ONCE https://t.co/wF2m09IuOI
December 18th 2017, 11:12pm
intercooleronli @intercooleronli
Analyzing Medivation $MDVN and Spark Therapeutics $ONCE https://t.co/oT6h8rvCT3
December 18th 2017, 11:12pm
TranscriptDaily @TranscriptDaily
Analyzing Medivation $MDVN and Spark Therapeutics $ONCE https://t.co/8hoIHPqUUh
December 18th 2017, 11:12pm
storminvestor @storminvestor
Deciphera Pharmaceuticals $DCPH & Medivation $MDVN Head-To-Head Analysis https://t.co/bjQ8mp7YBD
December 18th 2017, 9:12am
SPNewsAnalysis @SPNewsAnalysis
Deciphera Pharmaceuticals $DCPH & Medivation $MDVN Head-To-Head Analysis https://t.co/YaoXMq1yed
December 18th 2017, 9:12am
ConsumerFeed @ConsumerFeed
Analyzing Deciphera Pharmaceuticals $DCPH & Medivation $MDVN https://t.co/eyDPa7M975
December 15th 2017, 1:12am
CFinancialNews @CFinancialNews
Analyzing Deciphera Pharmaceuticals $DCPH & Medivation $MDVN https://t.co/yP7eJmtCTS
December 15th 2017, 1:12am
dakotafinancial @dakotafinancial
Analyzing Deciphera Pharmaceuticals $DCPH & Medivation $MDVN https://t.co/wHtN3aB53H
December 15th 2017, 1:12am
ConsumerFeed @ConsumerFeed
Analyzing Deciphera Pharmaceuticals $DCPH & Medivation $MDVN https://t.co/6MGKuu6fCj #acn
December 15th 2017, 1:12am
AmericanBanking @AmericanBanking
Analyzing Deciphera Pharmaceuticals $DCPH & Medivation $MDVN https://t.co/NEgEJnpYnH
December 15th 2017, 1:12am
intercooleronli @intercooleronli
Analyzing Deciphera Pharmaceuticals $DCPH & Medivation $MDVN https://t.co/gVUcb2hi5T
December 15th 2017, 1:12am
SPNewsAnalysis @SPNewsAnalysis
Medivation $MDVN Earning Somewhat Favorable News Coverage, Analysis Finds https://t.co/8QNBPIqNLu
December 14th 2017, 8:12pm
storminvestor @storminvestor
Medivation $MDVN Earning Somewhat Favorable News Coverage, Analysis Finds https://t.co/RLG9r6MD5K
December 14th 2017, 8:12pm
intercooleronli @intercooleronli
Medivation $MDVN and Its Peers Head to Head Contrast https://t.co/M0nWG0BtZU
December 12th 2017, 3:12am
ConsumerFeed @ConsumerFeed
Medivation $MDVN and Its Peers Head to Head Contrast https://t.co/pDe58d4jUR #acn
December 12th 2017, 3:12am
CFinancialNews @CFinancialNews
Medivation $MDVN and Its Peers Head to Head Contrast https://t.co/zSznTKZUMm
December 12th 2017, 3:12am
IRAMarketReport @IRAMarketReport
Medivation $MDVN and Its Peers Head to Head Contrast https://t.co/m64deY25BX
December 12th 2017, 3:12am
AmericanBanking @AmericanBanking
Medivation $MDVN and Its Peers Head to Head Contrast https://t.co/S467AFJAV9
December 12th 2017, 3:12am
chaffeybreeze @chaffeybreeze
Medivation $MDVN and Its Peers Head to Head Contrast https://t.co/bp53dTEE5Q
December 12th 2017, 3:12am
TheMarketsDaily @TheMarketsDaily
Somewhat Favorable Media Coverage Somewhat Unlikely to Affect Medivation $MDVN Stock Price https://t.co/yhxzsIstpX
December 10th 2017, 9:12pm
DrSteinberg @DrSteinberg
$PFE PARPi acquired from $MDVN (talazoparib) data presented at #SABCS17 mPFS 8.6 months v. 5.6 (chemo) compared… https://t.co/draqzFm6T3
December 8th 2017, 9:12am
HindsightTrades @HindsightTrades
What a bust. $MDVN
December 8th 2017, 8:12am
ahaskett8 @ahaskett8
@UnknownPatriot7 @stockwizard69 Look at $MDVN which burned tons of cash, commercialized a drug, had a few quarters… https://t.co/tKAJzMaeDZ
November 26th 2017, 10:11pm
SleekMoneycom @SleekMoneycom
Medivation $MDVN Getting Somewhat Favorable Media Coverage, Analysis Finds https://t.co/zr6HFD2E0U
November 8th 2017, 8:11am

Contact © thinkBiotech LLC 2004 - 2018. All rights reserved.